Sage Therapeutics

SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders.

Industries

Stage

Post IPO Equity

Employees

501-1,000

Links

Org chart

Collapse
Matt Lasmanis
Chief Technology & Innovation Officer
Chris Benecchi
Chief Business Officer
Al Robichaud
Chief Scientific Officer
Jeff Jonas
Chief Innovation Officer
Jim Doherty
Chief Development Officer
Erin Lanciani
Chief People & Experience Officer
Laura Gault
Chief Medical Officer
Anne Marie Cook
SVP & General Counsel
Tammy J. Phinney
SVP, Regulatory Affairs
Vanessa Procter
SVP, External Affairs
Abdul J. Sankoh
SVP, Data Science
Mark Pollack
SVP of Global Medical Affairs